+86-28-82633987
ISO ISO
ISO 17025 ISO 17025
usp usp
EN
CN EN

Ginsenoside RK2

BP1473
364779-14-6
98%
Phytounique
Ginsenoside Rk1 has anti-tumor, and anti-platelet aggregation activities. Ginsenoside Rk1 can strongly inhibit permeability induced by VEGF, advance glycation end-product, thrombin, or histamine in human retinal endothelial cells, it reduces the vessel leakiness of retina in a diabetic mouse model; this anti-permeability activity of Rk1 is correlated with enhanced stability and positioning of tight junction proteins at the boundary between cells; Rk1 induces phosphorylation of myosin light chain and cortactin, which are critical regulators for the formation of the cortical actin ring structure and endothelial barrier.
Catalog No Package Original Price Price Inventory Quantity Operating
BP1473-5mg 5mg
BP1473-10mg 10mg
BP1473-20mg 20mg
BP1473-100mg 100mg
Chengdu Biopurify Phytochemicals Ltd.
Chengdu Biopurify Phytochemicals Ltd.

Ginsenoside RK2 Related Products

Product drug property prediction parameters

  • 189.9000

  • -2.5000

  • -2.5000

  • Low

  • No

  • No

  • No

  • No

  • No

  • Unknown

  • No

Ginsenoside RK2 Reference LiteratureMORE+